Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Special Issue: Current evidence and perspectives for hypertension management in Asia
  • Published:

Association of nighttime very short-term blood pressure variability determined by pulse transit time with adverse prognosis in patients with heart failure

A Comment to this article was published on 17 February 2025

Abstract

Long-term blood pressure (BP) variability (BPV) is associated with adverse prognosis in patients with heart failure. However, the clinical significance of very short-term (beat-to-beat) BPV is unclear. We collected data on nighttime pulse transit time-based continuous beat-to-beat BP measurement in patients with heart failure (n = 366, median age 72.0, male sex 53.3%). Coefficient of variation (CoV) of pulse transit time-based BP was considered as very short-term BPV. The primary outcome was a composite of heart failure hospitalization or cardiac death. Median values (25th and 75th percentiles) of systolic and diastolic BP CoV were 3.6% (2.8%, 4.5%) and 5.1% (3.8%, 6.5%), respectively. During a median follow-up period of 1084 days after BPV evaluation, 71 patients experienced the primary outcome. When the patients were divided into tertiles based on the systolic and diastolic BPV, the primary outcome occurred most frequently in the highest tertile of BPV. Multivariable Cox proportional hazard analysis revealed that systolic and diastolic BPV, as continuous variables, were independently associated with the primary outcome (hazard ratio 1.199 and 1.101, respectively). In conclusion, high nighttime very short-term BPV was associated with adverse prognosis in patients with heart failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  2. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  3. Suzuki Y, Kaneko H, Okada A, Fujiu K, Takeda N, Morita H, et al. BP classification using the 2017 ACC/AHA BP guidelines with risk of cardiovascular events in older individuals. J Cardiol. 2024;84:394–403.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  5. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  6. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014;32:2285–95.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  7. Butler J, Kalogeropoulos AP, Georgiopoulou VV, Bibbins-Domingo K, Najjar SS, Sutton-Tyrrell KC, et al. Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart. 2011;97:1304–11.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  8. Group SR, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl J Med. 2015;373:2103–16.

    ArticleĀ  Google ScholarĀ 

  9. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49:1265–70.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  10. Mancia G. Short- and long-term blood pressure variability: present and future. Hypertension. 2012;60:512–7.

    ArticleĀ  CASĀ  Google ScholarĀ 

  11. Sheikh AB, Sobotka PA, Garg I, Dunn JP, Minhas AMK, Shandhi MMH, et al. Blood Pressure Variability in Clinical Practice: Past, Present and the Future. J Am Heart Assoc. 2023;12:e029297.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  12. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143–55.

    ArticleĀ  Google ScholarĀ 

  13. Narita K, Shimbo D, Kario K. Assessment of blood pressure variability: characteristics and comparison of blood pressure measurement methods. Hypertens Res. 2024;47:3345–55.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  14. Mehlum MH, Liestol K, Kjeldsen SE, Julius S, Hua TA, Rothwell PM, et al. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. Eur Heart J. 2018;39:2243–51.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  15. Suchy-Dicey AM, Wallace ER, Mitchell SV, Aguilar M, Gottesman RF, Rice K, et al. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens. 2013;26:1210–7.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  16. Kario K, Kanegae H, Hoshide S. Home blood pressure stability score is associated with better cardiovascular prognosis: data from the nationwide prospective J-HOP study. Hypertens Res. 2024. https://doi.org/10.1038/s41440-024-01940-z. e-pub ahead of print 20241012.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  17. Chichareon P, Methavigul K, Lip GYH, Krittayaphong R. Systolic blood pressure visit-to-visit variability and outcomes in Asian patients with atrial fibrillation. Hypertens Res. 2024;47:1479–89.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  18. Gesche H, Grosskurth D, Kuchler G, Patzak A. Continuous blood pressure measurement by using the pulse transit time: comparison to a cuff-based method. Eur J Appl Physiol. 2012;112:309–15.

    ArticleĀ  Google ScholarĀ 

  19. Misaka T, Niimura Y, Yoshihisa A, Wada K, Kimishima Y, Yokokawa T, et al. Clinical impact of sleep-disordered breathing on very short-term blood pressure variability determined by pulse transit time. J Hypertens. 2020;38:1703–11.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  20. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217–26.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  21. Vidan MT, Bueno H, Wang Y, Schreiner G, Ross JS, Chen J, et al. The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail. 2010;12:148–55.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  22. Sato Y, Yoshihisa A, Oikawa M, Nagai T, Yoshikawa T, Saito Y, et al. Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction. Int Heart J. 2019;60:876–85.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  23. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79:e263–e421.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  24. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  25. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure- Digest Version. Circ J. 2019;83:2084–184.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  26. Monzo L, Ferreira JP, Abreu P, Szumski A, Bohm M, McMurray JJV, et al. Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial. J Hypertens. 2020;38:420–5.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  27. Ferreira JP, Duarte K, Pitt B, Dickstein K, McMurray JJV, Zannad F, et al. Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials. J Hypertens. 2018;36:1736–42.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  28. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147–239.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  29. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  30. Misaka T, Sato Y, Sugawara Y, Ogawara R, Ichimura S, Tomita Y, et al. Elevated blood bicarbonate levels and long-term adverse outcomes in patients with chronic heart failure. ESC Heart Fail. 2024. https://doi.org/10.1002/ehf2.14900.

  31. Ichimura S, Misaka T, Ogawara R, Tomita Y, Anzai F, Sato Y, et al. Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy. Circ Heart Fail. 2024;17:e011057.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  32. Ogawara R, Misaka T, Ohashi N, Ichimura S, Tomita Y, Tani T, et al. Very short-term blood pressure variability by pulse transit time-based measurements during night-time predicts future cardiovascular events in patients with ischemic heart disease. Clin Res Cardiol. 2024. https://doi.org/10.1007/s00392-024-02539-7.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  33. Sato Y, Yoshihisa A, Sugawara Y, Misaka T, Sato T, Kaneshiro T, et al. Malnutrition stratified by marasmus and kwashiorkor in adult patients with heart failure. Sci Rep. 2024;14:19722.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  34. Rickham PP. Human Experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J 1964;2:177.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  35. Ferber R, Millman R, Coppola M, Fleetham J, Murray CF, Iber C, et al. Portable recording in the assessment of obstructive sleep apnea. ASDA Stand Pract Sleep. 1994;17:378–92.

    CASĀ  Google ScholarĀ 

  36. Misaka T, Yoshihisa A, Yokokawa T, Takeishi Y. Effects of continuous positive airway pressure on very short-term blood pressure variability associated with sleep-disordered breathing by pulse transit time-based blood pressure measurements. J Hypertens. 2023;41:733–40.

    CASĀ  PubMedĀ  Google ScholarĀ 

  37. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Yokota T, Ide T, Takeshita A, et al. Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009;73:1442–7.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  38. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Yokota T, Takeshita A, Yokoshiki H, et al. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009;73:1901–8.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  39. Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep. 2012;14:421–31.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  40. Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017;14:30–8.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  41. Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med. 2006;119:S47–53.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  42. Minatoguchi S. Heart failure and its treatment from the perspective of sympathetic nerve activity. J Cardiol. 2022;79:691–7.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  43. Arundel C, Lam PH, Gill GS, Patel S, Panjrath G, Faselis C, et al. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2019;73:3054–63.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  44. Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, et al. Clinical Characteristics and Outcomes of Hospitalized Patients With Heart Failure From the Large-Scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF). Circ J. 2021;85:1438–50.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  45. Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, et al. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2018;3:288–97.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  46. Mitchell GF. Arterial Stiffness in Aging: Does It Have a Place in Clinical Practice?: Recent Advances in Hypertension. Hypertension. 2021;77:768–80.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  47. Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020;76:719–34.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  48. Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, et al. Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study. J Cardiol. 2024. https://doi.org/10.1016/j.jjcc.2024.09.002.

  49. Girerd N, Coiro S, Benson L, Savarese G, Dahlstrom U, Rossignol P, et al. Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure Registry. Eur J Heart Fail. 2024;26:359–69.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  50. Sogunuru GP, Kario K, Shin J, Chen CH, Buranakitjaroen P, Chia YC, et al. Morning surge in blood pressure and blood pressure variability in Asia: Evidence and statement from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2019;21:324–34.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

Download references

Acknowledgements

The authors thank Kumiko Watanabe, Yumi Yoshihisa, Shiori Togashi, and Tomiko Miura for their technical assistance. The acquisition of data was supported by Ayumi Haneda, Akito Endo, Mari Hoshi, Manami Akimoto, Mimori Itami, Shiori Urayama, and Yuuichi Yokoyama from the Office for Diversity and Inclusion, Fukushima Medical University, Fukushima, Japan. The present study was supported in part by grants-in-aid for Scientific Research (23K06870 and 24K18648) from the Japan Society for the Promotion of Science.

Funding

Grant-in-aid for Scientific Research (23K06870 and 24K18648) from the Japan Society for the Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akiomi Yoshihisa.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, Y., Yoshihisa, A., Ohashi, N. et al. Association of nighttime very short-term blood pressure variability determined by pulse transit time with adverse prognosis in patients with heart failure. Hypertens Res 48, 1305–1314 (2025). https://doi.org/10.1038/s41440-025-02102-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41440-025-02102-5

Keywords

This article is cited by

Search

Quick links